The global exoskeleton
market is expected to reach USD 3.3 billion by 2025, according to
a new report published by Grand View Research. Key factors driving the market expansion
include the increasing number of U.S. FDA products, growing demand for
exoskeletons in rehabilitation, assisted walking, military applications, and
industrial applications.
The market is evolving rapidly due to the increasing
adoption of exoskeleton technology in the developed regions. The growing
geriatric population coupled with increasing number of people suffering with
paraplegia, tetraplegia, and other spinal cord injuries are major factors
boosting the usage rates of exoskeletons.
The exoskeleton market has gained high momentum after
the launch of products such as ReWalk bionic suit, Ekso GT exoskeleton.
Moreover, with the U.S. FDA approving the Parker Indego, commercialization of
exoskeleton devices is expected to increase significantly over the next few
years.
In the U.S., the Defense Advanced Research Projects
Agency (DARPA), National Aeronautics and Space Administration (NASA), and
National Institute of Health (NIH) have significantly contributed toward
technology development, research funding, and commercialization of these
devices.
- For instance, in 2014, Ekso Bionics received a P20 Exploratory
Grant from the NIH to continue the development of an exoskeleton prototype
for children.
- In October, 2015, Parker Hannifin Corporation announced that it had
agreed to supply Indego exoskeleton for a 4-year multicenter study for the
Department of Defense, which was funded by the U.S. Department of Defense
and the Congressionally Directed Medical Research Programs.
In the EU, the Robo-Mate project, which comprises of
12 partners from 7 European nations, has received a total funding of Euro 4.5
million by the 7th Framework Program for Research and Technological Development
of the European Union. Furthermore, classification of Cyberdyne HAL exoskeleton
as medical device in the EU and Japan has reinforced the growth prospects and
improved the reimbursement scenario.
Browse full research report on Exoskeleton Market: https://www.grandviewresearch.com/industry-analysis/exoskeleton-market
Further
Key Findings from the Study Suggest:
- The data published by the International Federation of Robotics
suggests that in 2014, nearly 272 exoskeletons were sold commercially, and
this number is anticipated to grow rapidly over the next few years.
- In 2015, the healthcare segment accounted for the maximum revenue
share of 54.1%. The use of exoskeletons for rehabilitation and assisted
living services is a key factor driving the segments growth. However, the
industrial segment is expected to emerge as the fastest growing with a
high CAGR of 58.8%. Increasing age of workforce coupled with growing
healthcare disorders are expected to boost the use of automation and drive
the sales of exoskeletons over the forecast period.
- In 2015, North America was a clear leader with a revenue share of
49.8%. The research on exoskeletons was primarily initiated with the USD
50 million funding received from DARPA, and subsequent grants from NIH and
NASA have contributed to the development of a strong ecosystem for the proliferation
of exoskeleton technology. Moreover, the U.S. Department of Veteran
Affairs had issued a national coverage policy for ReWalk robotic
exoskeleton systems for eligible veterans with spinal cord injury. This
policy is expected to significantly benefit the veterans and propel the
usage rates over the forecast period
- Asia Pacific is expected to emerge as the fastest growing region
with a CAGR of 57.4% during the forecast period. The growing geriatric
population in Japan and China, increase in the spinal cord injuries, and
growing industrialization in this region are expected promote the
utilization of exoskeletons for healthcare and industrial applications.
- The exoskeleton market is presently dominated by few key
participants such as ReWalk, Ekso Bionics, Cyberdyne, and Lockheed Martin.
Some of the new players include Rex Bionics, Hocoma, Panasonic- ActiveLink
and Parker Hannifin Corporation. Introduction of low cost exoskeletons is
expected to increase the competition and is also expected to benefit several
patients over the forecast period
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/medical-devices
Grand
View Research has segmented the exoskeleton market by type, technology, end
use, and region:
Exoskeleton
Market Technology (Type) Outlook (Market revenue in USD Million, 2013 - 2025)
- Mobile
Exoskeleton
- Stationary
Exoskeleton
Exoskeleton
Mobile Technology Market Outlook (Market Revenue in USD Million, 2013 - 2025)
- Active
- Passive
Exoskeleton
Stationary Technology Outlook (Market Revenue in USD Million, 2013 - 2025)
- Active
- Passive
Exoskeleton
Market Technology (Drive System) Outlook (Market Revenue in USD Million, 2013 -
2025)
- Pneumatic
Actuator
- Hydraulic
- Electric
Servo
- Electric
Actuator
- Fully
Mechanical
- Shape Memory
Alloy Actuator
Exoskeleton
Market End-User Outlook (Market Revenue in USD Million, 2013 - 2025)
- Healthcare
- Military
- Industrial
Exoskeleton
Market Regional Outlook (Market Revenue in USD Million, 2013 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Switzerland
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East
and Africa
- South Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment